Navigation Links
Radiofrequency Ablation Devices Market is Expected to Reach USD 1.0 Billion Globally in 2018: Transparency Market Research
Date:7/22/2013

Albany, NY (PRWEB) July 22, 2013

According to a new market report published by Transparency Market Research, "Radiofrequency Ablation Devices Market for Pain Management- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global radiofrequency ablation devices market for pain management was valued at USD 296.6 million in 2011, and is expected to grow at a CAGR of 19.4% from 2012 to 2018, and to reach an estimated value of USD 1,027.6 million in 2018.

Related Report : Biosensors Market
http://www.transparencymarketresearch.com/biosensors-market.html

Radiofrequency ablation is a minimally invasive surgical procedure involving temperature controlled destruction of dysfunctional or cancerous tissues. Use of this technology for pain management refers to heat destruction of nerves conducting pain impulses, to relieve the patient of chronic pain. The market for RF ablation devices for pain management application is expected to record a high growth rate during the forecast period, owing to the rising demand of minimally invasive surgeries, high efficacy and short duration of the procedure.

The disposables segment accounted for the largest share of the market in 2011 and is expected to be the fastest growing segment during the forecast period. This was followed by the capital equipment segment and the reusables segment in 2011. Geographically, North America accounted for the largest share in 2011, while Asia-Pacific is expected to be the fastest growing region from 2012 to 2018 at a CAGR of 20.6%.

Browse the full report with TOC at http://www.transparencymarketresearch.com/radiofrequency-ablation-devices.html

This market is dominated by a few major players, namely, Cosman Medical, Integra-Radionics, Kimberly Clark-Baylis, NeuroTherm and Stryker Corporation. Of these, Kimberly-Clark accounted for the largest market share in 2011, followed by NueroTherm.

Radiofrequency ablation is a medical procedure involving use of high frequency electromagnetic waves to generate heat which is used to treat a medical condition. This technology finds application in various fields of medicine like tumor ablation in oncology, cardiac rhythm management, endometrial ablation in gynecology, renal denervation for hypertension, cosmetology and pain management. This report focuses on the RF ablation devices market for the pain management application area. The basic principle underlying pain management using RF ablation is heating up the nerves that send pain signals to the affected area so that their impulse transfer activity is hampered.

Browse All Market Research Reports: http://www.transparencymarketresearch.com/

Read the full story at http://www.prweb.com/releases/2013/7/prweb10950371.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. GAP-AF study helps to define optimal approach to ablation
2. New ablation technique holds promise for liver cancer patients
3. INTIO Introduces Intra-Procedural SyncVIEW™ for Real-time Confirmation of the Ablation Zone
4. Gold standards of success defined for AF ablation
5. Fine tuning cardiac ablation could lead to quicker results for patients with arrhythmias
6. Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent)
7. Endoscopy Devices Market Worth $9.7 Billion by 2016 - New Report by MarketsandMarkets
8. Mesh Lawsuits Involving C.R. Bard, Ethicon Transvaginal Mesh Devices Continue to Mount in New Jersey State Litigation, Bernstein Liebhard LLP Reports
9. Manufacturers Failed to Warn About Defective Transvaginal Mesh Devices, Parker Waichman LLP Alleges in Lawsuit
10. Spinal Surgery and Implants Devices Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
11. Rijuven Debuts CardioSleeve, an FDA Cleared Stethoscope Attachment with 3-Lead ECG and Digital Auscultation that Wirelessly Connects to Mobile Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 2017 , ... According to the American Cancer Society , the average ... 95%. Once the cancer spreads to other organs, bones, or lymph nodes, however, the ... avoid this latter group, tune in to Lifestyle Magazine on April 9, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... agreement to resolve the pending litigation between itself and 1800 Vending DBA Healthy ... Utah). , “I am thrilled to announce that we have now reached a ...
(Date:3/27/2017)... ... March 27, 2017 , ... Harris Communications, Inc., a leading provider of ... products to the Deaf Seniors of America Conference, April 4-7 at the Hotel Westin ... knowledgeable ASL friendly staff from Harris Communications and to try out the newest assistive ...
(Date:3/24/2017)... Hatboro, Pennsylvania (PRWEB) , ... March 24, 2017 ... ... and recycling solutions for contaminated soil, dredged material, and hazardous and non-hazardous materials ... headquartered in Allentown, Pennsylvania. This acquisition will add four additional processing facilities ...
(Date:3/24/2017)... ... , ... Digital Scientists, a software innovation lab specializing in web design and ... South Carolina location. The lab has set up shop at the renowned NEXT ... South Carolina clients for years from our office here in Atlanta,” explains Digital Scientists’ ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 24, 2017  GenomeDx Biosciences today announced that six ... Decipher® Prostate Cancer Classifier tests will be presented at ... (EAU) Congress held March 24 to 28, 2017 in ... Congress is Europe,s largest urological ... the urological field. The abstract titled "Muscle ...
(Date:3/24/2017)... DALLAS , March 23, 2017  HealthMine surveys ... January 2017 revealed that health plan members want help ... reason to stay engaged in their health, 2) help ... an integrated platform for health and 5) relevant, real-time ... outcomes and lowering healthcare costs. ...
(Date:3/24/2017)... 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... oncology and dermatology biopharmaceutical company, today disclosed terms ... Sheet (the "Definitive Financing") it entered into on ... stockholders, who are referred to in the Definitive ... filed with the Securities and Exchange Commission.   ...
Breaking Medicine Technology: